tiprankstipranks
Advertisement
Advertisement

Artrya Seeks ASX Quotation for 1.2 Million New Shares

Story Highlights
  • Artrya has applied to list 1,215,476 new fully paid ordinary shares on the ASX.
  • The new shares arise from exercised options or convertibles, modestly expanding Artrya’s tradable equity base.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Artrya Seeks ASX Quotation for 1.2 Million New Shares

Claim 55% Off TipRanks

An announcement from Artrya Limited ( (AU:AYA) ) is now available.

Artrya Limited has applied to the Australian Securities Exchange for quotation of 1,215,476 new ordinary fully paid shares, to be listed under its existing ticker AYA. The new securities result from the exercise or conversion of existing options or other convertible securities and will expand the company’s quoted share capital once admitted to trading.

The issuance of these additional shares modestly increases Artrya’s free float and may have implications for shareholder dilution and liquidity in the stock. By progressing this application, the company is formalising the transition of previously unquoted or conditional equity into fully tradeable securities, aligning its capital structure with prior option or convertible commitments.

The most recent analyst rating on (AU:AYA) stock is a Sell with a A$3.00 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.

More about Artrya Limited

Artrya Limited is an Australia-listed company trading under the ASX code AYA. The specific industry, core products and services, and target markets are not described in the provided release.

Average Trading Volume: 507,531

Technical Sentiment Signal: Buy

Current Market Cap: A$494.8M

See more insights into AYA stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1